Видео ютуба по тегу Medicines: Tucatinib

Tucatinib for the Treatment of HER2+ Breast Cancer
Tucatinib for the Treatment of HER2+ Breast Cancer
The Benefits of Tucatinib in HER2+ Breast Cancer
The Benefits of Tucatinib in HER2+ Breast Cancer
HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer
HER2CLIMB-02: tucatinib + TDM-1 in advanced breast cancer
Tucatinib and trastuzumab in the treatment paradigm of HER2-positive mCRC
Tucatinib and trastuzumab in the treatment paradigm of HER2-positive mCRC
Tucatinib Combination Improved Survival in HER2–Positive Breast Cancer
Tucatinib Combination Improved Survival in HER2–Positive Breast Cancer
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC
HER2CLIMB-05: tucatinib + trastuzumab and pertuzumab as maintenance therapy for HER2+ metastatic BC
Dr. Blackwell Discusses Tucatinib in HER2+ Breast Cancer
Dr. Blackwell Discusses Tucatinib in HER2+ Breast Cancer
MOUNTAINEER: Tucatinib plus trastuzumab for HER2+ metastatic colorectal cancer
MOUNTAINEER: Tucatinib plus trastuzumab for HER2+ metastatic colorectal cancer
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer
HER2CLIMB-04: tucatinib + trastuzumab deruxtecan in HER2+ breast cancer
Choosing between tucatinib and T-DXd in HER2+ breast cancer
Choosing between tucatinib and T-DXd in HER2+ breast cancer
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic...
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-positive metastatic...
TUKYSA (tucatinib)- unresectable or metastatic HER2-positive breast cancer
TUKYSA (tucatinib)- unresectable or metastatic HER2-positive breast cancer
HER2CLIMB: tucatinib efficacious against brain metastases in patients with HER2+ breast cancer
HER2CLIMB: tucatinib efficacious against brain metastases in patients with HER2+ breast cancer
Dr. Hamilton Discusses Tucatinib in HER2+ Breast Cancer
Dr. Hamilton Discusses Tucatinib in HER2+ Breast Cancer
FORCE tucatinib video
FORCE tucatinib video
Dr. Bekaii-Saab on the Rationale to Explore Tucatinib/Trastuzumab in HER2-Overexpressing mCRC
Dr. Bekaii-Saab on the Rationale to Explore Tucatinib/Trastuzumab in HER2-Overexpressing mCRC
HER2CLIMB-04: tucatinib plus T-DXd for HER2+ breast cancer
HER2CLIMB-04: tucatinib plus T-DXd for HER2+ breast cancer
Pharmacology of Tucatinib for treatment of breast cancer (New Drug 2020)
Pharmacology of Tucatinib for treatment of breast cancer (New Drug 2020)
HER2CLIMB-05: tucatinib improves progression-free survival in HER2+ metastatic breast cancer
HER2CLIMB-05: tucatinib improves progression-free survival in HER2+ metastatic breast cancer
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
HER2CLIMB: tucatinib with trastuzumab and capecitabine for HER2+ breast cancer with brain metastases
HER2CLIMB: tucatinib with trastuzumab and capecitabine for HER2+ breast cancer with brain metastases
Dr. O’Shaughnessy on the Utility of Tucatinib in the HER2+ Breast Cancer Brain Metastases
Dr. O’Shaughnessy on the Utility of Tucatinib in the HER2+ Breast Cancer Brain Metastases
HER2CLIMB-05: the role of tucatinib in HER2-positive metastatic breast cancer
HER2CLIMB-05: the role of tucatinib in HER2-positive metastatic breast cancer
Updated analysis from MOUNTAINEER: tucatinib and trastuzumab for HER2-positive mCRC
Updated analysis from MOUNTAINEER: tucatinib and trastuzumab for HER2-positive mCRC
MOUNTAINEER: tucatinib in combination with trastuzumab for HER2-positive metastatic colorectal c...
MOUNTAINEER: tucatinib in combination with trastuzumab for HER2-positive metastatic colorectal c...